Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.805 USD | +4.34% | 0.00% | -45.65% |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Jun. 05 | Coherus BioSciences, Inc. Appoints Rita Karachun to Its Board of Directors | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.65% | 198M | |
+17.48% | 124B | |
+15.83% | 109B | |
-6.77% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-9.25% | 16.61B | |
-37.63% | 16.43B | |
+2.48% | 13.4B | |
+25.73% | 11.47B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024